Yoko Yokoyama
Overview
Explore the profile of Yoko Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
1770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimoto T, Uchida K, Sato K, Yokoyama Y, Onoyama A, Fujita K, et al.
Alzheimers Dement (N Y)
. 2025 Mar;
11(1):e70062.
PMID: 40065916
Introduction: Cognitive training is a key component of multidomain interventions to prevent cognitive decline; however, low adherence remains a challenge. In this post hoc analysis of the Japan-Multimodal Intervention Trial...
2.
Sugimoto T, Uchida K, Yokoyama Y, Onoyama A, Fujita K, Kuroda Y, et al.
JAR Life
. 2025 Mar;
14:100003.
PMID: 40046640
Background: Intervention adherence is crucial to ensure cognitive benefits in trials designed to prevent cognitive decline. During the coronavirus disease 2019 (COVID-19) pandemic, the Japan-Multimodal Intervention Trial for the Prevention...
3.
Sekiguchi A, Ishikawa M, Uchiyama A, Yokoyama Y, Ogino S, Torii R, et al.
J Dermatol Sci
. 2025 Feb;
PMID: 40000304
Background: Cryoablation is an integral therapeutic approach in dermatology for eliminating viral warts and benign tumors by damaging tissue through freeze-thaw cycles. Rapid thawing of the frozen area by warming...
4.
Sekiguchi A, Ishikawa M, Uchiyama A, Yokoyama Y, Ogino S, Torii R, et al.
J Dermatol Sci
. 2025 Feb;
PMID: 39984390
No abstract available.
5.
Fujita K, Sugimoto T, Noma H, Kuroda Y, Matsumoto N, Uchida K, et al.
J Am Med Dir Assoc
. 2025 Feb;
26(4):105497.
PMID: 39956153
Objectives: The increasing number of patients with dementia necessitates the development of rapid and convenient tools to assist with dementia diagnosis. We previously demonstrated the difference in the postural control...
6.
Kuroda Y, Fujita K, Sugimoto T, Uchida K, Yokoyama Y, Shimazu T, et al.
J Alzheimers Dis
. 2025 Feb;
104(1):269-282.
PMID: 39924864
BackgroundDementia impacts individuals, families, and society, necessitating effective prevention strategies.ObjectiveTo evaluate the feasibility of a community-adapted multi-domain intervention for dementia prevention among older adults in Obu City, Japan and how...
7.
Ikenouchi M, Fukui H, Yagi S, Nogami A, Kaku K, Sato T, et al.
Intest Res
. 2025 Feb;
PMID: 39894450
Background/aims: Tofacitinib (TFB), filgotinib (FIL), and upadacitinib (UPA) are Janus kinase (JAK) inhibitors approved for moderate-to-severe ulcerative colitis (UC). The appropriate positioning of each JAK inhibitor in the treatment algorithm,...
8.
Yagi S, Fukui H, Ikenouchi M, Shiraishi T, Kaku K, Wakita M, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797304
Few studies have compared the efficacy and safety of Janus kinase (JAK) inhibitors in patients with ulcerative colitis (UC). We compared the real-world effectiveness and safety of tofacitinib (TOF) and...
9.
Sekiguchi A, Shimokawa C, Kato T, Uchiyama A, Yokoyama Y, Ogino S, et al.
Sci Rep
. 2025 Jan;
15(1):1423.
PMID: 39789188
Systemic sclerosis (SSc) is an idiopathic systemic connective tissue disorder characterized by fibrosis of the skin and internal organs, with growing interest in the imbalance between Th17 cells and regulatory...
10.
Kuroda Y, Goto A, Uchida K, Sugimoto T, Fujita K, Yokoyama Y, et al.
Cancer Med
. 2024 Oct;
13(20):e70311.
PMID: 39440694
Objective: The incidence rates of dementia, mild cognitive impairment, and cancer increase with age, posing challenges to affected individuals and their families. However, there are currently no clear cancer screening...